Chargement en cours...
Adoptive T-cell transfer therapy and oncogene targeted therapy for melanoma: The search for synergy
The clinical strengths of immunotherapy and small molecule inhibitors targeting the MAPK pathway appear to be largely complementary for the treatment of advanced melanoma. In current practice, most patients with BRAF V600 mutant melanomas will see both modalities. Several in vitro and in vivo studie...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845447/ https://ncbi.nlm.nih.gov/pubmed/24089442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0261 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|